Arş. Gör. ÖMÜR GÖKMEN SEVİNDİK

Yayın Ağı

Makaleler 5

1. Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry project

PINAR İ. E., Celik S., Polat M. G., Karatas A. F., Doğan A., ILTAR U., et al.

BMC Cancer , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

2. Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data

Birtas Atesoglu E., Gulbas Z., UZAY A., ÖZCAN M., ÖZKALEMKAŞ F., Dal M. S., et al.

Hematological Oncology , cilt.41, sa.4, ss.663-673, 2023 (SCI-Expanded, Scopus)

3. Clinical Outcomes and Treatment Patterns of Primary Central Nervous System Lymphoma: Multicenter Retrospective Analysis

GÜVEN S., YAVUZ B., Yucel E. E., KARATAŞ A. F., ÖZSAN G. H., DEMİRKAN F., et al.

Eurasian Journal of Medicine and Oncology , cilt.7, sa.1, ss.49-56, 2023 (Scopus, TRDizin)

4. Evaluation of Clinical and Pathological Characteristics of Patients with IgA Nephropathy Based on Oxford Classification System: Should Crescents be Included?

Ersan S., Sevindik O. G., ÇAVDAR C., Ada S., Sifil A., Celik A., et al.

BANTAO Journal , cilt.15, sa.1, ss.10-15, 2017 (Scopus)

5. IPSET-thrombosis better identifies thrombosis-free survival: A Turkish cohort

Sevindik O. G., Mersin S., Katgi A., TUNALI S., Solmaz S. M., Acar C., et al.

Clinical Lymphoma, Myeloma and Leukemia , cilt.15, sa.6, 2015 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 1

1. Comparing the efficacy of generic Imatinib formulations with the original Imatinib as the frontline tyrosine kinase inhibitor in chronic phase chronic myeloid leukemia

DEMİRKAN F., SEVİNDİK Ö. G., KARAMAN A., ALACACIOĞLU İ., Solmaz S. M., ÖZSAN G. H.

51st Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)

Metrikler

Arş. Gör. ÖMÜR GÖKMEN SEVİNDİK

Yayınlar & Eserler

1. Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry project

2. Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data

3. Clinical Outcomes and Treatment Patterns of Primary Central Nervous System Lymphoma: Multicenter Retrospective Analysis

4. Evaluation of Clinical and Pathological Characteristics of Patients with IgA Nephropathy Based on Oxford Classification System: Should Crescents be Included?

5. IPSET-thrombosis better identifies thrombosis-free survival: A Turkish cohort

1. Comparing the efficacy of generic Imatinib formulations with the original Imatinib as the frontline tyrosine kinase inhibitor in chronic phase chronic myeloid leukemia

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)